Scientists in Brazil are developing a vaccine against cocaine addiction, called Calixcoca. The vaccine has shown promising results in animal trials, and it is now set to enter human trials.
Calixcoca works by triggering the body to produce antibodies that bind to cocaine molecules in the bloodstream. These antibodies make the cocaine molecules too large to pass into the brain, where they would normally produce their euphoric effects.
The vaccine has also been shown to reduce the risk of overdose, and it may also protect nursing babies from the effects of cocaine.
If successful, Calixcoca could be a revolutionary new treatment for cocaine addiction. It would be the first vaccine to be used to treat any addiction, and it could help millions of people around the world to break free from cocaine dependence.
The development of Calixcoca is particularly significant in Brazil, which is the world’s second-largest consumer of cocaine. The vaccine could have a major impact on public health in Brazil, and it could also help to reduce crime and social problems associated with its addiction.
The human trials of Calixcoca are expected to begin in early 2024. If the trials are successful, the vaccine could be available to the public within a few years.
Source: Vox